Purple Biotech (PPBT) Current Leases (2019 - 2026)
Purple Biotech (PPBT) reported Current Leases of $184000.0 for Q1 2026, up 34.31% year-over-year from $137000.0 in Q1 2025, and down 24.59% quarter-over-quarter from $244000.0 in Q4 2025.
Purple Biotech (PPBT) Current Leases (2019 - 2026) Analysis & Trends
Purple Biotech (PPBT) has 8 years of Current Leases data on file, last reported at $184000.0 in Q1 2026.
- Current Leases for Q1 2026 came in at $184000.0, up 34.31% year-over-year; the trailing twelve-month figure through Mar 2026 was $184000.0 (up 34.31% YoY), and the FY2025 annual result was $244000.0, up 33.33% from the prior year.
- Current Leases retreated to $184000.0 in Q1 2026 per PPBT's latest filing, from $244000.0 in the prior quarter.
- Over five years, Current Leases peaked at $244000.0 in Q4 2025 and troughed at $103000.0 in Q2 2025.
- A 5-year average of $184117.6 and a median of $186000.0 in 2024 frame the typical range for Current Leases.
- The sharpest annual moves came in 2025 and 2026: Current Leases tumbled 43.41% in 2025, then soared 34.31% in 2026.
- A 5-year view of Current Leases shows it stood at $194000.0 in 2022, then fell by 3.09% to $188000.0 in 2023, then decreased by 2.66% to $183000.0 in 2024, then soared by 33.33% to $244000.0 in 2025, then dropped by 24.59% to $184000.0 in 2026.
- Business Quant data shows PPBT's Current Leases at $184000.0 in Q1 2026, $244000.0 in Q4 2025, and $207000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Purple Biotech | 261.30 Mn | 254.88 Mn | - | 184,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 184,000.00 |
| Dec 31, 2025 | 244,000.00 |
| Sep 30, 2025 | 207,000.00 |
| Jun 30, 2025 | 103,000.00 |
| Mar 31, 2025 | 137,000.00 |
| Dec 31, 2024 | 183,000.00 |
| Sep 30, 2024 | 184,000.00 |
| Jun 30, 2024 | 182,000.00 |
| Mar 31, 2024 | 186,000.00 |
| Dec 31, 2023 | 188,000.00 |
| Sep 30, 2023 | 178,000.00 |
| Jun 30, 2023 | 184,000.00 |
| Mar 31, 2023 | 189,000.00 |
| Dec 31, 2022 | 194,000.00 |
| Sep 30, 2022 | 193,000.00 |
| Jun 30, 2022 | 195,000.00 |
| Mar 31, 2022 | 199,000.00 |
| Dec 31, 2021 | 199,000.00 |
| Sep 30, 2021 | 199,000.00 |
| Jun 30, 2021 | 199,000.00 |